HomeDTC • CNSX
add
Defence Therapeutics Inc
Previous close
$1.50
Day range
$1.40 - $1.50
Year range
$1.12 - $3.30
Market cap
63.75M CAD
Avg Volume
42.67K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 8.29M | 339.73% |
Net income | -8.32M | -318.50% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -8.29M | -341.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 351.00K | 116.09% |
Total assets | 668.85K | 49.78% |
Total liabilities | 2.96M | 16.32% |
Total equity | -2.30M | — |
Shares outstanding | 45.04M | — |
Price to book | -30.00 | — |
Return on assets | -1,836.71% | — |
Return on capital | -9,978.41% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -8.32M | -318.50% |
Cash from operations | -1.39M | 35.76% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 394.52K | -82.56% |
Net change in cash | -999.11K | -3,262.45% |
Free cash flow | 1.65M | 209.82% |
About
Founded
2017
Headquarters
Website